Breaking News

Controversial new study on fluoride and IQ: what to know

January 6, 2025
Justin Sullivan/Getty Images

What to know about a controversial new study on fluoride and IQ

JAMA Pediatrics publishes review of 74 studies on fluoride and IQ alongside conflicting editorials on questions of neurocognitive harm and dental health benefits.

By Anil Oza


Why Medicaid cuts could be a 'crisis' for people with disabilities

If the new administration slashes federal Medicaid spending, millions of people with disabilities would be cut off from critical health care services.

By Timmy Broderick


FDA releases long-awaited guidance to improve accuracy of pulse oximeters for all skin tones 

The draft document recommends testing the devices on more people and provides clearer direction on the populations they should be tested on

By Usha Lee McFarling and Anil Oza



Mike Reddy for STAT

What Covid tried to teach us — and why it will matter in the next pandemic

Five years after the start of the outbreak, here are some issues we will likely have to deal with when the next pandemic hits.

By Helen Branswell


STAT+ | The biotech scorecard for the first quarter: 16 stock-moving events to watch

Stock-moving biotech events for the fourth quarter include clinical trial readouts from Ultragenyx, Akero Therapeutics, and Incyte.

By Adam Feuerstein


STAT+ | Hospitals now know how some health AI tools were developed. Will that change anything?

A new federal transparency rule requires some developers to disclose details about how their health AI tools were developed and tested.

By Mario Aguilar


Adobe

Opinion: How sedation policies can limit access to abortion care

Some hospital systems require all procedural abortions requiring sedation to be done in an operating room, an unnecessary policy limiting access.

By Skye A. Miner


STAT+ | FDA's new guidance on AI in drug development centers the risk introduced by the technology

After nearly a decade of machine learning innovations, the FDA has issued its first draft guidance on the use of AI in drug development.

By Katie Palmer


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments